1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition. Washington, DC: American Psychiatric Association; 1994.
2. Pine DS, McClure EB. Anksiyete bozuklukları: Klinik özellikleri. In: Aydın H, Bozkurt A, editor. Kaplan & Sadock's Comprehensive Textbook of Psychiatry. 8th Edition. Ankara: GüneŞ Kitabevi, 2007, p. 1768–1771.
3. Grillon C. Anxiety Disorders. Psychophysiological Aspects. In: Sadock BJ, Sadock VA, editor. Kaplan & Sadock's Comprehensive Textbook of Psychiatry. 8th Edition. Philadelphia: Lippincott Williams & Wilkins, 2005, p. 1728–1739.
4. Bayraktar E. Panik bozukluğu ve agorafobi. In: Işık E, Taner E, Işık U, editor. Güncel Klinik Psikiyatri. Ankara: Golden Print Matbaası, 2008, p. 209–222.
5. Yao JK, Reddy R, McElhinny LG, van Kammen DP. Effects of haloperidol on antioxidant defense system enzymes in schizophrenia. J Psychiatr Res 1998;32:385–391. PMID:
9844955.
6. Khan MM, Evans DR, Gunna V, Scheffer RE, Parikh VV, Mahadik SP. Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated fist-episode of psychosis and after years of treatment with antipsychotics. Schizophr Res 2002;58:1–10. PMID:
12363384.
7. Savas HA, Gergerlioglu HS, Armutcu F, Herken H, Yilmaz HR, Kocoglu E, et al. Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes. World J Biol Psychiatry 2006;7:51–55. PMID:
16428220.
8. Zhang XY, Tan YL, Cao LY, Wu GY, Xu Q, Shen Y, et al. Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics. Schizophr Res 2006;81:291–300. PMID:
16309894.
9. Bulut M, Selek S, Gergerlioglu HS, Savas HA, Yilmaz HR, Yuce M, et al. Malondialdehyde levels in adult attention-deficit hyperactivity disorder. J Psychiatry Neurosci 2007;32:435–438. PMID:
18043768.
10. Machado-Vieira R, Andreazza AC, Viale CI, Zanatto V, Cereser V Jr, da Silva Vargas R, et al. Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neurosci Lett 2007;421:33–36. PMID:
17548157.
11. Kehrer JP, Smith CV. Free Radicals in Biology: Sources, Reactivities, and Roles in the Etiology of Human Diseases. In: Frei B, editor. Natural Antioxidants in Human Health and Disease. San Diego: Academic Press, 1994, p. 25–62.
12. Halliwell B. Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radic Res 1996;25:57–74. PMID:
8814444.
13. Betteridge DJ. What is oxidative stress? Metabolism 2000;49:3–8. PMID:
10693912.
14. Niki E, Yoshida Y, Saito Y, Noguchi N. Lipid peroxidation: mechanisms, inhibition, and biological effects. Biochem Biophys Res Commun 2005;338:668–676. PMID:
16126168.
15. Seven A, Candan G. Serbest radikaller ve lipid peroksidasyonu. Klinik Gelişim 1995;8:3906–3911.
16. Ng F, Berk M, Dean O, Bush AI. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 2008;11:851–876. PMID:
18205981.
17. Kuloglu M, Atmaca M, Tezcan E, Ustundag B, Bulut S. Antioxidant enzyme and malondialdehyde levels in patients with panic disorder. Neuropsychobiology 2002;46:186–189. PMID:
12566935.
18. Herken H, Akyol O, Yilmaz HR, Tutkun H, Savas HA, Ozen ME, et al. Nitric Oxide, Adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: alterations by antidepressan treatment. Hum Psychopharmacol 2006;21:53–59. PMID:
16329160.
19. Ersoy MA, Selek S, Celik H, Erel O, Kaya MC, Savas HA, et al. Role of oxidative parameters in etiopathogenesis and prognosis of panic disorder. Int J Neurosci 2008;118:1025–1037. PMID:
18569158.
20. Yarpuz AY, Yılmaz A, Soykan A, Elgün S, Kumbasar H. Panik bozukluğunda adenozin deaminaz ve dipeptidil peptidaz IV enzim düzeyleri. Türk Psikiyatri Derg 2008;9:149–156.
21. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37:112–119. PMID:
14725941.
22. Ohkawa H, Ohishi N, Yagi K. Assay of lipid peroxides in animal tissue by thiobarbutiric acid reaction. Anal Biochem 1979;95:351–358. PMID:
36810.
23. Tükel R. Panik bozukluğu. Psikiyatri Dünyası 1997;1:12–17.
24. Eaton WW, Anthony JC, Romanoski A, Tien A, Gallo J, Cai G, et al. Onset and recovery from panic disorder in the Baltimore Epidemiologic Catchment Area follow-up. Br J Psychiatry 1998;173:501–507. PMID:
9926079.
25. AltıntaŞ EY. Panik Bozuklukta YaŞam Kalitesi: 3 Aylık İzlem ÇalıŞması. Uzmanlık Tezi. Adana: Çukurova Üniversitesi; 2006.
26. Kartalci S, Dogan M, Unal S, Ozcan AC, Ozdemir S, Atmaca M. Pituitary volume in patients with panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:203–207. PMID:
21075158.
27. Eren İ, Tükel R, Polat A, Karaman R, Ünal S. Panik bozukluğunda bölgesel kan akımı değiŞikliklerinin Tc99m-HMPAO SPECT ile değerlendirilmesi. Türk Psikiyatri Derg 2002;13:89–97. PMID:
12794661.
28. Şar V. DSM-5 Taslak Tanı Ölçütlerine Genel Bir Bakş: "Batı Cephesinde Yeni Bir Şey Yok'mu? Klin Psikiyatr Derg 2010;13:196–208.
29. Pham-Huy LA, He H, Pham-Huy C. Free radicals, antioxidants in disease and health. Int J Biomed Sci 2008;4:89–96. PMID:
23675073.
30. Halliwell B. Free radicals and other reactive species in disease. Encyclopedia of Life Sciences 2005;5:1–7.
31. Shinde A, Ganu J, Naik P. Effect of Free Radicals & Antioxidants on Oxidative Stress: A Review. J Dental Allied Sciences 2012;1:63–66.